Document is current

Any future updates will be listed below

Development and Implementation of a Comprehensive Initiative to Educate Healthcare Providers and Patients in the United States about the Risk of Drug-Drug Interactions Associated with Nirmatrelvir/ritonavir during the COVID-19 Pandemic

Crossref DOI link: https://doi.org/10.1007/s12247-024-09854-6

Published Online: 2024-09-28

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark